Document is current
Any future updates will be listed below
-
Authors
Killalea, Méabh M.
Borgeson, Jordan
Kane, Conor J.
Kovac, Jude
Greason, Christie
Gulati, Mayari A.
Schonfeld, Daniel A.
Crestanello, Maria M.
Zacher, Jessica
Tsaban, Gal
Lee, Eunjung
Malins, Jeffrey G.
Naser, Jwan A.
Poterucha, Timothy J.
Friedman, Paul A.
Lopez-Jimenez, Francisco
Kane, Garvan C.
Attia, Zachi I.
Thaden, Jeremy J.
Pislaru, Sorin V.
Bird, Jared G.
-
Funding
Funding for this research was provided by:
University College Dublin, Ireland
Mayo Clinic PULSE Research Program
Mayo Clinic
- License Information
-
More Information
Article History
Received: 22 September 2025
Accepted: 28 May 2026
First Online: 9 June 2026
Competing interests
: E.L., J.G.M., J.A.N., S.V.P., G.C.K. and Z.I.A. have invented algorithms licensed to UltraSight Ltd. Inc. and may benefit from algorithm commercialization via Mayo Clinic. P.A.F., F.L.-J. and Z.I.A. are members of the Scientific Advisory Board for Anumana, an AI company commercializing AI-ECG. F.L.-J. is a co-inventor of several algorithms using AI-ECG licensed to Anumana and a co-inventor of an artificial heart valve that has been licensed to Colibri Co. T.J.P. has research grant funds paid to affiliated institutions by Pfizer, Eidos Therapeutics, Janssen, the American Heart Association, and the Tianqiao and Chrissy Chen Foundation, stock ownership in Baxter and Abbott Laboratories, and is an inventor on a patent to use ECG analysis to detect structural heart disease. The remaining authors declare no competing interests.
